Inventors with similar research interests:
Location History:
- Hitachi, JP (1988 - 1998)
- Katsuta, JP (1995 - 2005)
- Ibaraki, JP (2001 - 2007)
- Hadano, JP (2008)
- Hitachinaka, JP (1999 - 2012)
- Chiba, JP (2006 - 2014)
- Kawasaki, JP (2015)
- Ota-ku, JP (2015)
- Nakahara-ku, JP (2018)
- Mobara, JP (2003 - 2020)
- Kodaira, JP (2017 - 2021)
- Minato-ku, JP (2021)
- Tokyo, JP (1991 - 2024)
Company Filing History:
23 out of 35,658 
21 out of 42,485 
19 out of 229 
Years Active: 1988-2025
Title: Tetsuya Nagata - Innovator in Nucleic Acid Therapeutics
Introduction
Tetsuya Nagata, based in Mobara, Japan, is a prominent inventor known for his significant contributions to the field of nucleic acid therapeutics. With an impressive portfolio of 107 patents, Nagata has been a driving force in the development of innovative therapies aimed at improving healthcare outcomes.
Latest Patents
Nagata's latest inventions focus on advancing the efficacy and safety of antisense nucleic acids. One of his notable patents is the development of a drug that enables highly-efficient skipping of exons, involving an antisense oligomer that connects multiple unit oligomers targeting sequences in the same exon without overlap. Additionally, he has developed a low toxicity antisense nucleic acid medicine designed to modulate the expression of target transcriptional products, particularly in the central nervous system. This innovation involves a nucleic acid complex formed by annealing a first nucleic acid strand with an antisense oligonucleotide region to a second complementary strand.
Career Highlights
Tetsuya Nagata has garnered extensive experience throughout his career, having worked with prestigious companies such as NEC Corporation and Hitachi, Ltd. His expertise in nucleic acid technology has been pivotal in pioneering novel therapeutic strategies that address critical healthcare challenges.
Collaborations
During his career, Nagata has collaborated with notable colleagues, including Shin'ichi Takeda and Naoki Watanabe. These collaborations have fostered a creative environment that has facilitated the advancement of groundbreaking innovations in the field of genetic medicine.
Conclusion
Tetsuya Nagata's contributions to the realm of nucleic acid therapeutics underscore his commitment to innovation in healthcare. With a remarkable patent portfolio and a history of influential collaborations, Nagata continues to inspire future generations of inventors and researchers in the pursuit of effective medical solutions. His work exemplifies the intersection of science and innovation in addressing complex health issues.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.